Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2022
Title: Innovator Spotlight: Su Ji Na and Her Contributions to SARS-CoV-2 Research
Introduction: Su Ji Na is an accomplished inventor based in Seoul, South Korea. She has made significant strides in the field of virology, particularly in developing solutions to combat the SARS-CoV-2 virus.
Latest Patents: Su Ji Na holds a patent for her groundbreaking composition for inhibiting the growth of SARS-CoV-2. The invention, titled "Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same," focuses on a composition that includes MDPX-V2021. This compound plays a vital role in inhibiting post-translational modification (PTM) stages in cells following the virus's entry into the body.
Career Highlights: Throughout her career, Su Ji Na has established herself as a key figure in pharmaceutical innovation. She has worked with notable companies, including Medicare Pharmaceuticals Inc. and Medicare L.C., where she honed her expertise and contributed significantly to research and development efforts in the industry.
Collaborations: In her professional journey, Su Ji Na has collaborated with fellow researchers, including Do Hyun Na and Kyung Pyo Kang. These partnerships have facilitated the exchange of ideas and have accelerated advancements in her area of expertise.
Conclusion: Su Ji Na's contributions to the field of virology demonstrate her dedication to scientific innovation. Her patented work in inhibiting SARS-CoV-2 illustrates the potential impact of her research on public health, highlighting the importance of inventors in tackling global challenges.